Intuitive Surgical (ISRG) was upgraded by Bank of America/Merrill Lynch from neutral to buy with a price target of $620 as the firm’s Da Vinci robot will gain market share in the US for surgeries. Shares are higher by about 1.2 percent.
Intuitive Surgical (ISRG) was upgraded by Bank of America/Merrill Lynch from neutral to buy with a price target of $620 as the firm’s Da Vinci robot will gain market share in the US for surgeries. Shares are higher by about 1.2 percent.
